SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002052
Filing Date
2022-08-05
Accepted
2022-08-05 08:46:22
Documents
44
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clrb-20220630x10q.htm   iXBRL 10-Q 894655
2 EX-31.1 clrb-20220630xex31d1.htm EX-31.1 12562
3 EX-31.2 clrb-20220630xex31d2.htm EX-31.2 12583
4 EX-32.1 clrb-20220630xex32d1.htm EX-32.1 12033
  Complete submission text file 0001410578-22-002052.txt   3662531

Data Files

Seq Description Document Type Size
5 EX-101.SCH clrb-20220630.xsd EX-101.SCH 27109
6 EX-101.CAL clrb-20220630_cal.xml EX-101.CAL 24809
7 EX-101.DEF clrb-20220630_def.xml EX-101.DEF 133772
8 EX-101.LAB clrb-20220630_lab.xml EX-101.LAB 219908
9 EX-101.PRE clrb-20220630_pre.xml EX-101.PRE 189297
38 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20220630x10q_htm.xml XML 527192
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 221138775
SIC: 2834 Pharmaceutical Preparations